---
schema_version: "secwatch.filing_event.v1"
accession: "0000055529-24-000037"
form_type: "8-K"
ticker: "KEQU"
cik: "0000055529"
company_name: "KEWAUNEE SCIENTIFIC CORP /DE/"
filed_at: "2024-12-11T23:59:59+00:00"
generated_at: "2026-05-29T04:52:50.004744+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Kewaunee Scientific Q2 FY2025: Sales down 5.3%, diluted EPS $1.01 vs $0.93 YoY; backlog record $184.4M

## Summary
- Net sales $47.8M (down 5.3% YoY); domestic sales up 6.5%, international down 30.1% due to India construction delays.
- Diluted EPS $1.01 vs $0.93 YoY; net earnings $3.0M vs $2.7M; EBITDA $4.9M.
- Record backlog $184.4M (Oct 31, 2024) vs $146.3M a year ago and $155.6M at April 30, 2024.
- Domestic segment net earnings $4.5M (up from $3.1M); international net earnings $0.4M (down from $0.5M).
- Incurred $2.3M in acquisition-related expenses for Nu Aire (closed Nov 1, 2024); adjusted diluted EPS would be $1.41.

## SEC filing metadata
- accession: 0000055529-24-000037
- form_type: 8-K
- ticker: KEQU
- cik: 0000055529
- company_name: KEWAUNEE SCIENTIFIC CORP /DE/
- filed_at: 2024-12-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/55529/000005552924000037/0000055529-24-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/55529/000005552924000037/kequ-20241211.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000055529-24-000037
- JSON: https://secwatch.observer/filing/0000055529-24-000037.json
- Plain text: https://secwatch.observer/filing/0000055529-24-000037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.